摘要
目的:探讨阿维A联合苦参素片治疗寻常性银屑病的临床疗效。方法:选择100例寻常性银屑病患者随机分为三组,两对照组分别为33例采用单独口服阿维A胶囊治疗和33例采用单独口服苦参素片治疗,观察组34例采用阿维A联合苦参素片口服治疗,比较三组的治疗效果。结果:治疗后三组的PASI评分均明显下降,前后比较差异有统计学意义(P<0.05),观察组治疗前后的评分差值与其余两组比较,差异均有统计学意义(P<0.05),两单独治疗组间比较,差异无统计学意义(P>0.05);观察组治疗的有效率明显高于其余两组(P<0.05),两单独治疗组间比较,差异无统计学意义(P>0.05)。结论:阿维A联合苦参素片治疗寻常性银屑病的效果明显优于单独治疗,疗效确切,安全性高,值得临床推广应用。
Objective To observe the clinical effect of avermectin A combined with kushenin tablets in the treatment of psoriasis vulgaris. Method 100 patients were randomly divided into three groups. In avermectin A group,33 patients were treated by avemectin A capsules. In kushenin group,33 patients were treated by kushenin tablets. In observation group,34 patients were treated by avermectin A combined with kushenin tablets. The effects of the three groups were compared. Results After treatment, the PASI scores of the three groups were all decreased significantly （P 〈 0. 05 ）. The reduction of observation group was significant than other groups （ P 〈 0. 05 ）. The differ- ence between avermectin A group and kushenin group was not statistically significant （ P 〉 0.05 ）. The effective rate of observation group was higher than other two groups （P 〈 0. 05） ,but the difference between avermectin A group and kushenin group was not statistically significant （P 〉 0. 05）. Conclusion Avermectin A combined with kushenin tablets in the treatment of psoriasis vulgaris are better than single treatments. The curative effect is exactly and the safety is high. It is worthy of clinical application.
出处
《吉林医学》
CAS
2014年第10期2035-2036,共2页
Jilin Medical Journal
关键词
阿维A
苦参素
寻常性银屑病
效果
Avermectin A
Oxymatrine
Psoriasis vulgaris
Effect
